EZH2 and Miyoshi myopathy: After using tazemetostat for systemic inhibition of EZH2, we established murine MM model in adipocyte-specific EZH2 genetic knockout C57BL/6 mice [12] and determine whether the EZH2 expressed in adipocytes affects MM therapeutic response.